M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 1004-1013

  Godár, Samuel ^a   Hořejší, Václav ^b   Weidle, Ulrich H ^c   Binder, Bernd R ^a   Hansmann, Cornelia ^a   Stockinger, Hannes ^a,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d Institute of Immunology VIRCC   (Austria)

Author keywords

Mannose 6 phosphate receptor; Monocyte; Plasminogen activator; Transforming growth factor; Urokinase receptor

Indexed keywords

PLASMIN; PLASMINOGEN; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0344026339     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q     Document Type: Article

References (51)

1. Massagué, J., The transforming growth factor-β family. Annu. Rev. Cell Biol. 1990. 6: 597-641.
2. Wahl, S. M., Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 1992. 12: 61-74.
3. McCartney-Francis, N. L. and Wahl, S. M., Transforming growth factor β: a matter of life and death. J. Leukoc. Biol. 1994. 55: 401-409.
4. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. and Doetschman, T., Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992. 359: 693-699.
5. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M. and Karlsson, S., Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 1993. 90: 770-774.
6. Borkowski, T. A., Letterio, J. J., Farr, A. G. and Udey, M. C., A role for endogenous transforming growth factor β1 in Langerhans cell biology: The skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 1996. 184: 2417-2422.
7. Harpel, J. G., Metz, C. N., Kojima, S. and Rifkin, D. B., Control of transforming growth factor-β activity: latency vs. activation. Prog. Growth Factor Res. 1992. 4: 321-335.
8. Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F. and Weinberg, R. A., Expression cloning and characterization of the TGF-β Type III receptor. Cell 1991. 67: 797-805.
9. Lin, H. Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R. A. and Lodish, H. F., Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992. 68: 775-785.
10. Massagué, J., Receptors for the TGF-β family. Cell 1992. 69: 1067-1070.
11. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H. and Miyazono, K., Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993. 75: 681-692.
12. Heldin, C.-H., Miyazono, K. and ten Dijke, P., TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997. 390: 465-471.
13. Miyazono, K., Hellman, U., Wernstedt, C. and Heldin, C.-H., Latent high molecular weight complex of transforming growth factor β1. J. Biol. Chem. 1988. 263: 6407-6415.
14. Taipale, J. and Keski-Oja, J., Growth factors in the extracellular matrix. FASEB J. 1997. 11: 51-59.
15. Flaumenhaft, R. and Rifkin, D. B., The extracellular regulation of growth factor action. Mol. Biol. Cell 1992. 3: 1057-1065.
16. Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M. and Plow, E. F., A potential basis of the thrombotic risks associated with lipoprotein(a). Nature 1989. 339: 301-303.
17. Lyons, R. M., Keski-Oja, J. and Moses, H. L., Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 1988. 106: 1659-1665.
18. Lyons, R. M., Gentry, L. E., Purchio, A. F. and Moses, H. L., Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol. 1990. 110: 1361-1367.
19. Plow, E. F., Freaney, D. E., Plescia, J. and Miles, L. A., The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell. Biol. 1986. 103: 2411-2420.
20. Rom, W. N., Human mononuclear phagocytes express the insulin-like growth factor-II/mannose-6-phosphate receptor. Am. J. Respir. Cell. Mol. Biol. 1991. 4: 555-559.
21. Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P. and Bouck, N., Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 1998. 93: 1159-1170.
22. Kornfeld, S., Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu. Rev. Biochem. 1992. 61: 307-330.
23. Purchio, A. F., Cooper, J. A., Brunner, A. M., Lioubin, M. N., Gentry, L. E., Kovacina, K. S., Roth, R. A. and Marquardt, H., Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor. J. Biol. Chem. 1988. 263:14211-14215.
24. Kovacina, K. S., Steele-Perkins, G., Purchio, A. F., Lioubin, M., Miyazono, K., Heldin, C.-H. and Roth, R. A., Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem. Biophys. Res. Commun. 1989. 160: 393-403.
25. Dennis, P. A. and Rifkin, D. B., Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 1991. 88: 580-584.
26. Odekon, L. E., Blasi, F. and Rifkin, D. B., Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 1994. 158: 398-407.
27. Nunes, I., Shapiro, R. L. and Rifkin, D. B., Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 1995. 155: 1450-1459.
28. Herbert, J. M. and Carmeliet, P., Involvement of u-PA in the anti-apoptotic activity of TGFβ for vascular smooth muscle cells. FEBS Lett. 1997. 413: 401-404.
29. Plow, E. F., Herren, T., Redlitz, A., Miles, L. A. and Hoover-Plow, J. L., The cell biology of the plasminogen system. FASEB J. 1995. 9: 939-945.
30. Ellis, V. and Danø, K., The urokinase receptor and the regulation of cell surface plasminogen activation. Fibrinolysis 1992. 6: 27-34.
31. Štefanová, I., Hořejší, V., Ansotegui, I. J., Knapp, W. and Stockinger, H., GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991. 254: 1016-1019.
32. Bohuslav, J., Hořejši, V., Hansmann, C., Stöckl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W. and Stockinger, H., Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 1995. 181: 1381-1390.
33. McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L. and Wahl, S., TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 1990. 4: 27-35.
34. Ehart, M., Koshelnick, Y., Stockinger, H. and Binder, B. R., Interactions of uPAR - impact on receptor regulation and signal transduction. Fibrinolysis 1998. 12: 211-217.
35. Stockinger, H., Ebel, T., Hansmann, C., Koch, C., Majdic, O., Prager, E., Patel, D. D., Fox, D. A., Hořejši, V., Sagawa, K. and Shen, D.-C., CD147 (neurothelin/ basigin) workshop panel report. In Kishimoto, T., Kikutani, H., von dem Borne, A. E. G. K., Goyert, S. M., Mason, D. Y., Miyasaka, M., Moretta, L., Okumura, K., Shaw, S., Springer, T. A., Sugawara, K. and Zola, H. (Eds.) Leukocyte Typing VI. Garland Publishing, Inc., New York 1997, pp 760-763.
36. Cesarman, G. M., Guevara, C. A. and Hajjar, K. A., An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 1994. 269: 21198-21203.
37. Nykjaer, A., Christensen, E. I., Vorum, H., Hager, H., Petersen, C. M., Roigaard, H., Min, H. Y., Vilhardt, F., Moller, L. B., Kornfeld, S. and Gliemann, J., Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell Biol. 1998. 141: 815-828.
38. Behrendt, N., Rønne, E. and Danø, K., The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol. Chem. Hoppe-Seyler 1995. 376: 269-279.
39. Twardzik, D. R., Mikovits, J. A., Ranchalis, J. E., Purchio, A. F., Ellingsworth, L. and Ruscetti, F. W., γ-interferon-induced activation of latent transforming growth factor-β by human monocytes. Ann. N. Y. Acad. Sci. 1990. 593: 276-284.
40. Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. S. and Degen, J. L., Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996. 87: 709-719.
41. Flaumenhaft, R., Abe, M., Mignatti, P. and Rifkin, D. B., Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J. Cell Biol. 1992. 118: 901-909.
42. Sitrin, R. G., Todd, R. F. I., Mizukami, I. F., Gross, T. J., Shollenberger, S. B. and Gyetko, M. R., Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 1994. 84: 1268-1275.
43. Grotendorst, G. R., Smale, G. and Pencev, D., Production of transforming growth factor β by human peripheral blood monocytes and neutrophils. J. Cell. Physiol. 1989. 140: 396-402.
44. Schalch, L., Rordorf-Adam, C., Dasch, J. R. and Jungi, T. W., IgG-stimulated and LPS-stimulated monocytes elaborate transforming growth factor type β (TGF-β) in active form. Biochem. Biophys. Res. Commun. 1991. 174: 885-891.
45. Sato, Y., Tsuboi, R., Lyons, R., Moses, H. and Rifkin, D. B., Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 1990. 111: 757-763.
46. Rifkin, D. B., Cross-talk among proteases and matrix in the control of growth factor action. Fibrinolysis Proteolysis 1997. 11: 3-9.
47. Chen, R.-H., Ebner, R. and Derynck, R., Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993. 260: 1335-1338.
48. Kolanus, W., Nagel, W., Schiller, B., Zeitlmann, L., Godar, S., Stockinger, H. and Seed, B., αLβ2 integrin/ LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996. 86: 233-242.
49. Cinek, T. and Hořejší, V., The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J. Immunol. 1992. 149: 2262-2270.
50. Baier, G., Baier-Bitterlich, G., Couture, C., Telford, D., Giampa, L. and Altmann, A., An efficient expression, purification and immunodetection system for recombinant gene products. Biotechniques 1994. 17: 94-99.
51. Rønne, E., Behrendt, N., Ploug, M., Nielsen, H. J., Wöllisch, E., Weidle, U., Dano, K. and Høyer-Hansen, G., Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J. Immunol. Methods 1994. 167: 91-101.